A significant sector of the pharmaceutical business, the ophthalmic Drugs market focuses on treatments for a range of eye diseases, including glaucoma, macular degeneration, and dry eye syndrome. Ageing populations, rising rates of eye diseases, and advances in technology are some of the causes. Major stakeholders spend in R&D for new pharmaceuticals and better treatments,...